These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 9014757
1. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line. Gonzalez Manzano R, Versanvoort C, Wright K, Twentyman PR. Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757 [Abstract] [Full Text] [Related]
3. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG. Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [Abstract] [Full Text] [Related]
5. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Twentyman PR, Rhodes T, Rayner S. Eur J Cancer; 1994 Dec; 30A(9):1360-9. PubMed ID: 7999426 [Abstract] [Full Text] [Related]
6. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines. Grandjean F, Brémaud L, Verdier M, Robert J, Ratinaud MH. Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872 [Abstract] [Full Text] [Related]
7. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo. Stein U, Walther W, Lemm M, Naundorf H, Fichtner I. Int J Cancer; 1997 Sep 04; 72(5):885-91. PubMed ID: 9311609 [Abstract] [Full Text] [Related]
8. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines. Robson C, Wright KA, Twentyman PR, Lambert PA, Griffin RJ. Biochem Pharmacol; 1998 Oct 01; 56(7):807-16. PubMed ID: 9774142 [Abstract] [Full Text] [Related]
9. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression. Coley HM, Workman P, Twentyman PR. Br J Cancer; 1991 Mar 01; 63(3):351-7. PubMed ID: 1672252 [Abstract] [Full Text] [Related]
11. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression. Chao CC. FEBS Lett; 1995 Oct 16; 373(3):285-90. PubMed ID: 7589484 [Abstract] [Full Text] [Related]
13. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance. Uchiyama-Kokubu N, Watanabe T. Anticancer Drugs; 2001 Oct 16; 12(9):769-79. PubMed ID: 11593059 [Abstract] [Full Text] [Related]
15. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells. Ichihashi N, Kitajima Y. Br J Dermatol; 2001 Apr 16; 144(4):745-50. PubMed ID: 11298532 [Abstract] [Full Text] [Related]
16. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells. Narasaki F, Oka M, Fukuda M, Ikeda K, Terashi K, Takatani H, Nakamura T, Soda H, Kohno S. Anticancer Res; 1997 Apr 16; 17(5A):3493-7. PubMed ID: 9413193 [Abstract] [Full Text] [Related]
20. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB. Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]